Clinical Trials · NCT07739537
PATHS-T2D: A Recall-by-Genotype Study of Physiologic and Pharmacologic Responses
- Phase
- Phase 4
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Massachusetts General Hospital
- Enrollment
- 100
- Start date
- Oct 2026
- Locations
- See registry
- Primary endpoint
- Physiologic characterization by MMTT